Michelle Gaiotto is a healthcare venture capital investor at HTH who combines statistical training with over $1 billion in cross-asset investment management experience, giving her an unusually quantitative perspective compared to many early-stage healthcare VCs. She serves as both CEO of HTH and actively leads financings while taking board positions at technical medical companies, positioning her as both a firm leader and hands-on deal champion who invests globally from her base in Italy. Michelle Gaiotto is a healthcare venture capital investor at HTH who combines statistical training with over $1 billion in cross-asset investment management experience, giving her an unusually quantitative perspective compared to many early-stage healthcare VCs. She serves as both CEO of HTH and actively leads financings while taking board positions at technical medical companies, positioning her as both a firm leader and hands-on deal champion who invests globally from her base in Italy.